Y Combinator appeared to be the VC, which was created in 2005. The main office of represented VC is situated in the Mountain View. The fund was located in North America if to be more exact in United States.
The current fund was established by Andrew Levy, Jessica Livingston, Paul Graham, Robert Morris, Trevor Blackwell. We also calculated 25 valuable employees in our database.
Among the most popular portfolio startups of the fund, we may highlight Airbnb, Stripe, Dropbox. We can highlight the next thriving fund investment areas, such as E-Commerce, Health Care. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Y Combinator, startups are often financed by FundersClub, Tikhon Bernstam, Kima Ventures. The meaningful sponsors for the fund in investment in the same round are ZhenFund, Yunqi Partners, Winklevoss capital. In the next rounds fund is usually obtained by Yuri Milner, Vy Capital, Transmedia Capital.
The typical startup value when the investment from Y Combinator is 500 millions - 1 billion dollars. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is generally included in more than 49 deals every year. Comparing to the other companies, this Y Combinator performs on 18 percentage points less the average number of lead investments. The high activity for fund was in 2019. Considering the real fund results, this VC is 3 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.
|$125K||01 Jan 2022||-|
|$10M||09 Dec 2021||New York, New York, United States|
|$25M||08 Dec 2021||London, England, United Kingdom|
|$1M||07 Dec 2021||-|
|$62M||06 Dec 2021||Mountain View, California, United States|
|$4M||02 Dec 2021||San Francisco, California, United States|
|$683K||26 Nov 2021||Auckland, Auckland, New Zealand|
|$1M||25 Nov 2021||-|
|$2M||24 Nov 2021||New Delhi, Delhi, India|
– Fintech startup Prospa raised $3.8m pre-seed funding.
– The round was led by Y Combinator and joined by other investors.
– The startup wants to change how banks serve micro and small businesses in Nigeria.
– Centaur Labs, a medical data labeling company, announced $15 million in funding to advance their mission to label the world’s medical data.
– The Series A round was led by Matrix Partners with participation from other funds including Accel, Global Founders Capital, Susa Ventures, Y Combinator, and individual investors including John Capodilupo (founder and CTO of WHOOP), Tom Lee (founder of One Medical), and Elliot Cohen (founder and CPO of PillPack).
– The new capital will fund the expansion of the company’s global network of labelers and accelerate product development and hiring.
– Artificial intelligence is enabling extraordinary advances in healthcare, with the potential to reduce costs and drastically improve healthcare outcomes. However, AI is only as accurate as the data it is trained on.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.